Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Change in Inventory of -$33000.0 for Q1 2026, up 92.65% year-over-year from -$17129.5 in Q1 2025, and up 98.93% quarter-over-quarter from -$3.1 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Change in Inventory history runs 7 years deep, the most recent figure standing at -$33000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 92.65% year-over-year to -$33000.0; the TTM figure through Mar 2026 stood at -$7.6 million (down 126283.33% YoY), while the FY2025 annual figure was -$8.0 million, down 2021.75% from the prior year.
- Change in Inventory for Q1 2026 stood at -$33000.0, up from -$3.1 million in the prior quarter.
- The five-year high for Change in Inventory was $8.7 million in Q2 2022, with the low at -$19.3 million in Q4 2022.
- The 5-year median for Change in Inventory is -$452000.0 (2024), against an average of -$1.1 million.
- The sharpest annual moves came in 2023 and 2025: Change in Inventory surged 381.68% in 2023, then tumbled 584.07% in 2025.
- Maravai Lifesciences Holdings' Change in Inventory stood at -$19.3 million in 2022, then surged by 111.33% to $2.2 million in 2023, then tumbled by 120.7% to -$452000.0 in 2024, then sank by 584.07% to -$3.1 million in 2025, then surged by 98.93% to -$33000.0 in 2026.
- Business Quant data shows MRVI's Change in Inventory at -$33000.0 in Q1 2026, -$3.1 million in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn | 768,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 768,000.00 |
| Jun 30, 2026 | 768,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Dec 31, 2025 | -3.09 Mn |
| Dec 31, 2025 | -3.09 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Mar 31, 2025 | -449,000.00 |
| Mar 31, 2025 | -449,000.00 |
| Dec 31, 2024 | -452,000.00 |
| Dec 31, 2024 | -452,000.00 |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | -702,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Mar 31, 2024 | -820,000.00 |
| Mar 31, 2024 | -820,000.00 |